» Articles » PMID: 17296794

Complementation Between Mouse Mfn1 and Mfn2 Protects Mitochondrial Fusion Defects Caused by CMT2A Disease Mutations

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2007 Feb 14
PMID 17296794
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

Mfn2, an oligomeric mitochondrial protein important for mitochondrial fusion, is mutated in Charcot-Marie-Tooth disease (CMT) type 2A, a peripheral neuropathy characterized by axonal degeneration. In addition to homooligomeric complexes, Mfn2 also associates with Mfn1, but the functional significance of such heterooligomeric complexes is unknown. Also unknown is why Mfn2 mutations in CMT2A lead to cell type-specific defects given the widespread expression of Mfn2. In this study, we show that homooligomeric complexes formed by many Mfn2 disease mutants are nonfunctional for mitochondrial fusion. However, wild-type Mfn1 complements mutant Mfn2 through the formation of heterooligomeric complexes, including complexes that form in trans between mitochondria. Wild-type Mfn2 cannot complement the disease alleles. Our results highlight the functional importance of Mfn1-Mfn2 heterooligomeric complexes and the close interplay between the two mitofusins in the control of mitochondrial fusion. Furthermore, they suggest that tissues with low Mfn1 expression are vulnerable in CMT2A and that methods to increase Mfn1 expression in the peripheral nervous system would benefit CMT2A patients.

Citing Articles

Cellular ATP demand creates metabolically distinct subpopulations of mitochondria.

Ryu K, Fung T, Baker D, Saoi M, Park J, Febres-Aldana C Nature. 2024; 635(8039):746-754.

PMID: 39506109 PMC: 11869630. DOI: 10.1038/s41586-024-08146-w.


The dysfunction of complement and coagulation in diseases: the implications for the therapeutic interventions.

Jiang H, Guo Y, Wang Q, Wang Y, Peng D, Fang Y MedComm (2020). 2024; 5(11):e785.

PMID: 39445002 PMC: 11496570. DOI: 10.1002/mco2.785.


Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator.

Weigele J, Zhang L, Franco A, Cartier E, Dorn 2nd G J Pharmacol Exp Ther. 2024; 391(2):361-374.

PMID: 39284622 PMC: 11493442. DOI: 10.1124/jpet.124.002258.


Mfn2-dependent fusion pathway of PE-enriched micron-sized vesicles.

Penalva D, Monnappa A, Natale P, Lopez-Montero I Proc Natl Acad Sci U S A. 2024; 121(30):e2313609121.

PMID: 39012824 PMC: 11287154. DOI: 10.1073/pnas.2313609121.


MFN2 coordinates mitochondria motility with α-tubulin acetylation and this regulation is disrupted in CMT2A.

Kumar A, Larrea D, Pero M, Infante P, Conenna M, Shin G iScience. 2024; 27(6):109994.

PMID: 38883841 PMC: 11177149. DOI: 10.1016/j.isci.2024.109994.


References
1.
Delettre C, Lenaers G, Griffoin J, Gigarel N, Lorenzo C, Belenguer P . Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000; 26(2):207-10. DOI: 10.1038/79936. View

2.
Chan D . Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol. 2006; 22:79-99. DOI: 10.1146/annurev.cellbio.22.010305.104638. View

3.
Santel A, Fuller M . Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001; 114(Pt 5):867-74. DOI: 10.1242/jcs.114.5.867. View

4.
Rojo M, Legros F, Chateau D, Lombes A . Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci. 2002; 115(Pt 8):1663-74. DOI: 10.1242/jcs.115.8.1663. View

5.
Stowers R, Megeath L, Gorska-Andrzejak J, Meinertzhagen I, Schwarz T . Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron. 2002; 36(6):1063-77. DOI: 10.1016/s0896-6273(02)01094-2. View